for resistance to other FQs. It absolutely does.
HOWEVER, THIS DOES NOT MEAN THAT YOU SHOULD JUST USE CARBAPENEMS-LINEZOLID FOR EVERY PATIENT WHO WALKS THROUGH THE DOOR BECAUSE NOTHING MATTERS!
And here's where the messaging could have been more nuanced.
@DrToddLee@ABsteward Wow, didn't know about this...I'm sure it works in vitro. I believe clinicians in my hospital like mero/vab better, but I don't know if this is the reason.
@DrToddLee@ABsteward Also does nothing on metallo beta lactamases, which are the most frequent in Pseudomonas. Imi/rel was not designed as an anti-pseudomonas drug.
@vivax74@ABsteward According to EUCAST, Pseudomonas is always SDD (breakpoint for S is 0.001 if I remember correctly), which means therapy is always high dose, standard dose would be 12g/day.
Any microbiologist out here who has been using Chatbots for their bioinformatics/computational needs? I want to know more about their experience.
Please RT for visibility! 🙂
We are excited to share our latest publication on the utility of a commercial kit for the isolation of vesicles from clinical strains of Pseudomonas aeruginosa 🧫 #Pseudomonas#OMVs@JournalSpectrum https://t.co/66LnN4NSRY